IBX 2.86% 6.8¢ imagion biosystems limited

Ann: Imagion Biosystems December 2021 Investor Newsletter, page-2

  1. 47 Posts.
    lightbulb Created with Sketch. 289

    Hi all,

    Imagion is very pleased to share we have released ourDecember 2021 Investor Newsletter today.

    In thislatest edition, Imagion’s Executive Director and CEO Bob Proulx gives an updateon the Company’s recent activities, highlighting the progress in our MagSensePhase 1 clinical trial.

    You can also read more from the Principal Investigator forour study at Lake Macquarie, an introduction to our new Director of Operations,Carmen Soikowski, and other relevant company news – including alook at our new facility.

    We thank you for your continued support of ourcompany and the work we are doing to develop our technology.

    You can read the newsletter here.
    Last edited by ImagionBio: 16/12/21
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
(20min delay)
Last
6.8¢
Change
-0.002(2.86%)
Mkt cap ! $2.219M
Open High Low Value Volume
6.2¢ 6.8¢ 6.2¢ $691 10.78K

Buyers (Bids)

No. Vol. Price($)
1 8295 6.2¢
 

Sellers (Offers)

Price($) Vol. No.
6.9¢ 11500 1
View Market Depth
Last trade - 13.11pm 15/07/2024 (20 minute delay) ?
IBX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.